PTGS2 and cancer: For this reason, COX inhibitors, including the large class of non-steroidal anti-inflammatory drugs (NSAIDs), as well as the COX-2 selective inhibitors (e.g., celecoxib), are suggested for cancer prevention, especially as colon adenocarcinoma is concerned [16].